DNA Polymerases as Targets of Anticancer Nucleosides
Journal:
Current Drug Targets
Volume:
5
Page:
191-195
Author(s):
Shinji Miura and Shunji Izuta
Identification and Targeting of Tumor Escape Mechanisms: A New Hope for Cancer Therapy?
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2009-2023
Author(s):
Elke S. Bergmann-Leitner, Elizabeth H. Duncan and Wolfgang W. Leitner
Preface [Hot topic: Implications of COX-2 Inhibition in the Gastrointestinal Tract (Executive Editor : Angel Lanas)]
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
ii-ii
Author(s):
Angel Lanas
COX-2 and Colorectal Cancer
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2229-2251
Author(s):
A. Ferrandez, S. Prescott and R. W. Burt
Cyclooxygenase-2 Inhibition and Gastric Cancer
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2281-2288
Author(s):
Xiao Hua Jiang and C. Y. Wong
Tumoral Drug Metabolism: Perspectives and Therapeutic Implications
Journal:
Current Drug Metabolism
Volume:
4
Page:
131-149
Author(s):
M. M. Doherty and M. Michael
Cancer and Phase II Drug-Metabolizing Enzymes
Journal:
Current Drug Metabolism
Volume:
4
Page:
45-58
Author(s):
S. A. Sheweita and A. K. Tilmisany
Histone Deacetylase Inhibitors and Anticancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
477-484
Author(s):
G. Kouraklis and S. Theocharis
Porphyrins in Photodynamic Therapy - A Search for Ideal Photosensitizers
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
187-207
Author(s):
S. K. Pushpan, S. Venkatraman, V. G. Anand, J. Sankar, D. Parmeswaran, S. Ganesan and T. K. Chandrashekar
The Role of dUTPase and Uracil-DNA Repair in Cancer Chemotherapy
Journal:
Current Protein & Peptide Science
Volume:
2
Page:
361-370
Author(s):
Robert D. Ladner